Here's the live share price of Caplin Point Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories | 8.44 | 11.73 | 5.39 | -4.57 | -2.37 | 39.33 | 26.12 |
| Sun Pharmaceutical Industries | 2.16 | 7.80 | 8.37 | 8.82 | 4.59 | 24.30 | 21.48 |
| Divi's Laboratories | 3.13 | 14.07 | 9.69 | 0.25 | 12.60 | 26.85 | 10.15 |
| Torrent Pharmaceuticals | 4.41 | 8.66 | 9.53 | 14.64 | 37.49 | 37.95 | 25.91 |
| Cipla | 2.89 | 10.85 | 0.39 | -10.97 | -9.35 | 13.05 | 8.40 |
| Lupin | 3.22 | 3.68 | 8.14 | 19.65 | 18.08 | 48.09 | 14.23 |
| Dr. Reddy's Laboratories | -2.26 | 8.52 | 1.42 | 7.89 | 12.56 | 9.63 | 3.94 |
| Mankind Pharma | 8.04 | 18.85 | 16.54 | 8.54 | -0.29 | 19.45 | 11.25 |
| Zydus Lifesciences | 5.20 | 5.21 | 1.61 | -0.96 | 7.59 | 21.33 | 8.49 |
| Aurobindo Pharma | 7.12 | 11.49 | 23.91 | 29.09 | 28.51 | 33.98 | 7.28 |
| Glenmark Pharmaceuticals | -1.66 | 8.80 | 19.77 | 29.08 | 67.09 | 60.82 | 30.47 |
| Alkem Laboratories | 3.02 | 6.10 | -3.13 | -1.98 | 12.72 | 16.50 | 12.94 |
| Laurus Labs | 11.86 | 13.54 | 24.68 | 22.77 | 109.80 | 54.98 | 20.17 |
| Biocon | 5.84 | 8.73 | 1.78 | -0.44 | 13.73 | 15.93 | -0.20 |
| Abbott India | 5.70 | 3.97 | -2.18 | -8.87 | -10.47 | 6.12 | 10.79 |
| Anthem Biosciences | 3.24 | 13.71 | 16.53 | 11.25 | 7.40 | 2.41 | 1.44 |
| GlaxoSmithKline Pharmaceuticals | 6.38 | 5.52 | -1.05 | -2.19 | -9.35 | 25.36 | 11.33 |
| Ipca Laboratories | 1.64 | 7.66 | 7.21 | 15.65 | 15.26 | 30.32 | 8.34 |
| Ajanta Pharma | 7.42 | 11.97 | 6.14 | 20.05 | 20.51 | 33.42 | 17.77 |
| J B Chemicals & Pharmaceuticals | 5.26 | 10.81 | 14.42 | 18.88 | 40.27 | 27.39 | 24.79 |
Over the last one year, Caplin Point Laboratories has declined 2.37% compared to peers like Sun Pharmaceutical Industries (4.59%), Divi's Laboratories (12.60%), Torrent Pharmaceuticals (37.49%). From a 5 year perspective, Caplin Point Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.48%) and Divi's Laboratories (10.15%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,750.73 | 1,769.56 |
| 10 | 1,748.69 | 1,751.29 |
| 20 | 1,729.73 | 1,726.56 |
| 50 | 1,679.68 | 1,714.71 |
| 100 | 1,757.72 | 1,763.31 |
| 200 | 1,909.43 | 1,840.34 |
In the latest quarter, Caplin Point Laboratories remained same as its previous close in promoter holding, while DII stake increased to 2.14%, FII holding fell to 6.15%, and public shareholding moved up to 21.14% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 3,76,835 | 1.36 | 56.71 | |
| 3,21,369 | 0.92 | 48.36 | |
| 2,88,287 | 0.71 | 43.38 | |
| 1,45,000 | 2.07 | 21.82 | |
| 1,22,550 | 0.41 | 18.44 | |
| 10,449 | 0.74 | 1.57 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 07, 2026, 10:15 PM IST IST | Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 07, 2026, 09:37 PM IST IST | Caplin Point Lab. - Board Meeting Intimation for Approval Of Financial Results And Declaration Of Interim Dividend, If Any, A |
| May 05, 2026, 06:04 AM IST IST | Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Apr 06, 2026, 08:51 PM IST IST | Caplin Point Lab. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 13, 2026, 05:22 PM IST IST | Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 752.41 Cr. and Equity Capital is Rs. 15.20 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Caplin Point Laboratories is ₹1,855.00 as on May 08, 2026.
The Caplin Point Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Caplin Point Laboratories is ₹14,100.17 Cr as on May 08, 2026.
Today’s highest and lowest price of Caplin Point Laboratories are ₹1,871.35 and ₹1,845.00.
The 52-week high/low is the highest and lowest price at which Caplin Point Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Caplin Point Laboratories is ₹2,396.95 and 52-week low of Caplin Point Laboratories is ₹1,502.45 as on May 08, 2026.
The Caplin Point Laboratories has shown returns of -0.6% over the past day, 11.73% for the past month, 5.39% over 3 months, -2.37% over 1 year, 39.33% across 3 years, and 26.12% over 5 years.
P/E ratio of and PB ratio of Caplin Point Laboratories are 22.98 and 4.24 on May 08, 2026. While the company gives a dividend yield of 0.32 per annum.